204 related articles for article (PubMed ID: 22622019)
41. Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway.
Ren S; Xing Y; Wang C; Jiang F; Liu G; Li Z; Jiang T; Zhu Y; Piao D
Int J Biochem Cell Biol; 2020 Aug; 125():105777. PubMed ID: 32504672
[TBL] [Abstract][Full Text] [Related]
42. A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer.
Perez SM; Dimastromatteo J; Landen CN; Kelly KA
Cells; 2021 Aug; 10(9):. PubMed ID: 34571866
[TBL] [Abstract][Full Text] [Related]
43. Naphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells.
Lin KL; Su JC; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
Toxicol In Vitro; 2010 Jun; 24(4):1158-67. PubMed ID: 20197088
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
45. A natural compound derivative P-13 inhibits STAT3 signaling by covalently inhibiting Janus kinase 2.
Huang H; Niu J; Wang F; Hu L; Yu Q
Invest New Drugs; 2019 Jun; 37(3):452-460. PubMed ID: 30073465
[TBL] [Abstract][Full Text] [Related]
46. Anlotinib inhibits the progress of colorectal cancer cells by antagonizing VEGFR/JAK2/STAT3 axis.
Jia ZX; Zhang Z; Li Z; Li A; Xie YN; Wu HJ; Yang ZB; Zhang HM; Zhang XM
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2331-2343. PubMed ID: 33755971
[TBL] [Abstract][Full Text] [Related]
47. Bigelovin inhibits STAT3 signaling by inactivating JAK2 and induces apoptosis in human cancer cells.
Zhang HH; Kuang S; Wang Y; Sun XX; Gu Y; Hu LH; Yu Q
Acta Pharmacol Sin; 2015 Apr; 36(4):507-16. PubMed ID: 25619393
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.
Sun Y; Moretti L; Giacalone NJ; Schleicher S; Speirs CK; Carbone DP; Lu B
J Thorac Oncol; 2011 Apr; 6(4):699-706. PubMed ID: 21325979
[TBL] [Abstract][Full Text] [Related]
49. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
50. A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling.
Liu L; Kritsanida M; Magiatis P; Gaboriaud N; Wang Y; Wu J; Buettner R; Yang F; Nam S; Skaltsounis L; Jove R
Cancer Biol Ther; 2012 Nov; 13(13):1255-61. PubMed ID: 22895078
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.
Judd LM; Menheniott TR; Ling H; Jackson CB; Howlett M; Kalantzis A; Priebe W; Giraud AS
PLoS One; 2014; 9(5):e95993. PubMed ID: 24804649
[TBL] [Abstract][Full Text] [Related]
52. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
[TBL] [Abstract][Full Text] [Related]
53. MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.
Liu L; Gaboriaud N; Vougogianopoulou K; Tian Y; Wu J; Wen W; Skaltsounis L; Jove R
Cancer Biol Ther; 2014 Feb; 15(2):178-84. PubMed ID: 24100507
[TBL] [Abstract][Full Text] [Related]
54. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
[TBL] [Abstract][Full Text] [Related]
55. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
56. The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.
Baskin R; Park SO; Keserű GM; Bisht KS; Wamsley HL; Sayeski PP
PLoS One; 2014; 9(8):e105568. PubMed ID: 25162558
[TBL] [Abstract][Full Text] [Related]
57. Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS.
Liang JR; Yang H
Biomed Pharmacother; 2020 May; 125():109585. PubMed ID: 32106377
[TBL] [Abstract][Full Text] [Related]
58. Apigetrin inhibits gastric cancer progression through inducing apoptosis and regulating ROS-modulated STAT3/JAK2 pathway.
Sun Q; Lu NN; Feng L
Biochem Biophys Res Commun; 2018 Mar; 498(1):164-170. PubMed ID: 29408335
[TBL] [Abstract][Full Text] [Related]
59. An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway.
Xu X; Han K; Zhu J; Mao H; Lin X; Zhang Z; Cao B; Zeng Y; Mao X
Oncotarget; 2016 Nov; 7(46):75539-75550. PubMed ID: 27705908
[TBL] [Abstract][Full Text] [Related]
60. Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes.
Kandalam U; Clark MA
Regul Pept; 2010 Jan; 159(1-3):110-6. PubMed ID: 19748527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
